Clin Trans immunol 5:e60 Iwai T, Ito S, Tanimitsu K, Udagawa S, Oka J-I (2006) Glucagon-like peptide-1 inhibits LPS-induced IL-1 production in cultured rat astrocytes
Wegovy is approved by Health Canada for chronic weight management in adults with a specific BMI or weight-related health conditions
Physical health challenges include: Skin Infections and Irritation: Excess skin creates folds where moisture and bacteria accumulate Mobility Limitations: Loose skin can interfere with exercise and physical activities Hygiene Difficulties: Hard-to-clean skin folds increase infection risk Chronic Pain: Heavy, hanging skin can cause back and postural problems Psychological impacts often include: Body Image Disappointment: Feeling like your transformation is incomplete Clothing Fit Issues: Inability to properly showcase your new body shape Intimacy Concerns: Feeling self-conscious about loose skin Activity Avoidance: Reluctance to participate in beach activities or sports These challenges are particularly relevant in Miamis active, beach-focused lifestyle where form-fitting clothing and swimwear are part of daily life
Some studies suggest that individuals with obesity may have alterations in GLP-1 signaling, though findings are heterogeneous
9% with placebo (a substance that has no therapeutic effect), nausea (13%, 18% and 16%) vs
doi:10.1016/j.peptides.2017.11.015 222